Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group.
about
Effect of Ampicillin on the kinetics of colonization of Streptococcus pneumoniae and Lactobacillus fermentum in the respiratory tract of miceBritish Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community studyMacrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence studyLimiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children.Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae.Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.History of antibiotics. From salvarsan to cephalosporins.Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia.Paediatric community-acquired pneumonia: current concept in pharmacological control.Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in PakistanOvercoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional studyEpidemiological interpretation of studies examining the effect of antibiotic usage on resistanceA European study on the relationship between antimicrobial use and antimicrobial resistance.Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine.Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin.The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.High-dose versus standard-dose amoxicillin for acute otitis media.Quinolone resistance among pneumococci: therapeutic and diagnostic implications.Parent resistance to physicians' treatment recommendations: one resource for initiating a negotiation of the treatment decision.Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community.Penicillin use in pneumococcal disease.Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors
P2860
Q24797646-7FBD636B-1C24-4776-99CA-A60C159226F1Q30478714-CFB9A4AA-70A8-4313-B442-9B2F3E0CCA83Q30980181-FB622A4F-8931-4611-B053-97DD7AFF4422Q33756049-953A8EB5-0B58-412D-B935-8249C5D5AC80Q33817614-D7BB1BE7-AB3C-4023-BD5D-6E9A7D07260AQ33975560-CB18F80B-316D-4276-9DA9-D3F50E46FB96Q34031715-3DD8C548-74A9-4D6E-8448-C4D81AB2A108Q34192567-BFEA698E-3DAD-47BE-9080-4E26054F4A1FQ34192576-CA6A73F4-2A34-4905-A11E-20ABD1AF4BD8Q34262986-E88FDD78-8B41-47A5-B11A-91639ECD13D2Q34734294-22C0242B-25AB-4678-9574-474CD6DE8F9BQ35124715-A0168730-8B5A-49DD-9074-7CD9E123059DQ35567226-29F574D5-507F-4D86-AAB2-BAAB4941BDB7Q36022938-877B32F4-DDAA-486C-B78E-8C7911CBC423Q36155303-FDCDD29D-E4D7-488C-862A-48FBA657074EQ36170473-20F66C28-E773-45DA-A582-7913D9B1788BQ36359495-ECB1E80A-8B28-4047-816F-1613D796F632Q36452338-6A39539B-7719-43E1-B01F-4E822A3D6532Q36754258-FB7230F9-F9A8-4C10-907B-63884F5461F5Q36757737-B3294933-3D9A-48C7-8F5E-EC70A991CD88Q37320119-0B39FF5C-F64D-4570-ABB6-206A9A20F962Q37320160-F36ED82F-9A51-4A24-86EA-90B80A9DE3B7Q38344368-347C0DCD-D432-49A4-9A4E-762C632E2379Q38523119-7BFC85AB-1459-41C8-9C72-5DA53F5DCD30Q38682463-EDC93A16-D334-453A-A676-B24DB538B2A7Q40636919-AD28CD84-D61B-455B-AEB0-36962E5C493EQ44510164-F1E6B228-6195-402B-B356-46C05C69C587Q44741626-AD6DF919-7E85-4027-BA7D-5186C61C9564Q44883946-2FCC9530-3420-4C83-A59D-7EA6527F6215Q47790667-4E97C6AA-E75D-4813-8516-65158FE95018Q54032689-B579CE79-5741-487E-9C5D-23A819260117Q54037094-C35C8D95-9D8D-45E8-BD2D-F2F18CA94152Q57238021-DB880F67-4030-4066-BF58-564CCE2FAF74
P2860
Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@en
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@nl
type
label
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@en
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@nl
prefLabel
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@en
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@nl
P2093
P356
P1433
P1476
Risk factors and course of ill ...... ccus pneumoniae Working Group.
@en
P2093
Di Fabio JL
Kertesz DA
Ruvinsky R
P304
P356
10.1542/PEDS.103.2.409
P407
P577
1999-02-01T00:00:00Z